ASCENTAGE PHARMA GROUP INTERNATIONAL - SPONSORED ADS (AAPG)

CUSIP: 04390B105

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / SPONSORED ADS
Total 13F shares
81,771
Share change
-155,423
Total reported value
$3,219,883
Price per share
$39.38
Number of holders
11
Value change
-$2,881,943
Number of buys
9
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 04390B105?
CUSIP 04390B105 identifies AAPG - ASCENTAGE PHARMA GROUP INTERNATIONAL - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ASCENTAGE PHARMA GROUP INTERNATIONAL - SPONSORED ADS (AAPG) as of Q2 2025

As of 30 Jun 2025, ASCENTAGE PHARMA GROUP INTERNATIONAL - SPONSORED ADS (AAPG) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 81,771 shares. The largest 10 holders included Point72 (DIFC) Ltd, NEOS Investment Management LLC, TEMA ETFS LLC, HSBC HOLDINGS PLC, UBS Group AG, Chevy Chase Trust Holdings, LLC, XY Capital Ltd, MORGAN STANLEY, JPMORGAN CHASE & CO, and Bell Investment Advisors, Inc. This page lists 11 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.